STC Fall 2014 Breakfast Seminar Series STC.UNM, the University of New Mexico’s technology-transfer office, is hosting its spring breakfast seminar series. The seminars are free and open to the UNM community and the public, but registration is required. Breakfast will be provided.
“AIA Update: An Assessment of Current Domestic and Foreign Trends ”
Presented by Mr. Henry D. Coleman, Ph.D., J.D., Partner, CoSud Intellectual Property Solutions PC Auditorium, Building 800, UNM Science & Technology Park,… Show more 800 Bradbury SE, South Campus (free parking available in the parking garage directly west of Building 800, at the corner of Basehart and Bradbury Drive) Topic
Dr. Coleman will provide initial practical perspectives on the America Invents Act (AIA) and discuss its effect on the allowability of U. S. patents and foreign jurisdictional changes in patent practice.
Bio
Dr. Coleman is a Partner with the IP law firm CoSud Intellectual Property Solutions PC and has been in patent practice since 1985, with an emphasis on high-technology chemistry, pharmaceuticals, biotechnology, polymers, cosmetics, and medical devices and instrumentation.
He has over 29 years of experience in patent procurement and related proceedings, including interferences, before the United States Patent and Trademark Office in a variety of chemical, pharmaceutical, biotechnological and cosmetic technologies. He has extensive negotiating and licensing experience in technology transfer and joint venture research relationships, having negotiated agreements in the areas of cosmetics, pharmaceuticals, biotechnology, medical devices, contact lenses, polymer coatings, paint strippers, printing technology and related products. Dr. Coleman has patent and contract litigation experience (including arbitration experience) in the technical areas of contact lens copolymers, specialty chemicals, cosmetics and pharmaceuticals. Dr. Coleman also has extensive experience in conducting due diligence and providing opinions on patent matters, including licensing. He has been counsel in interference proceedings in the U.S. Patent and Trademark Office in the biotechnology and pharmaceutical arts. He is admitted to practice before the United States Patent and Trademark Office, the United States District Courts for the District of New Jersey, the Southern District of New York and the Eastern District of New York and before the Appellate Courts of the States of New York and New Jersey. He is also a member of the New Jersey Patent Law Association, New York Patent, Trademark and Copyright Association, Association of University Technology Managers and the American Chemical Society.
Dr. Coleman has completed graduate research in synthetic organic chemistry (nucleoside, carbohydrate, and heterocyclic), bio-organic chemistry (RNA and DNA phosphodiester and phosphotriester chemistry), biochemistry/pharmacology (RNA and DNA biochemistry, modified polymeric nucleoside cell uptake studies, cell culture techniques, and RNA and DNA purification), and drug design (design of anti-neoplastic DNA and RNA probes modified with unnatural nucleoside analogs for inhibition of reverse transcriptase and neoplasia). His Ph.D. thesis, "Studies on the Chemical Synthesis of Oligoribonucleotides Containing 5-Mercaptopyrimidine Bases," dealt with research on the design and chemical synthesis of modified deoxyribonucleic acid and ribonucleic acid.
He has experience in polymer research directing the development of novel gas permeable contact lens polymers, and served as Director of Polymer Research and Development at Permeable Technologies, Inc., directing polymer development in the contact lens area in concert with a joint venture research group from E.I. DuPont de Nemours & Company. He is a former Executive Vice-President of Permeable Technologies, and a co-inventor of three United States patents in the polymer chemistry area.
Dr. Coleman graduated from the State University of New York at Buffalo in 1977 with a B.S. in Pharmaceutical/Medicinal Chemistry (magna cum laude) and a B.A. in Political Science (magna cum laude), and in 1982 with a Ph.D. in Pharmaceutical/Medicinal Chemistry. Dr. Coleman attended the University of Wisconsin School of Law, graduating in 1985 (cum laude).
ABOUT STC.UNM As the technology-transfer and economic-development arm of the University of New Mexico, STC.UNM (formerly known as the Science & Technology Corporation @ UNM) protects and commercializes technologies developed at UNM by filing patents and copyrights and transferring these technologies to the marketplace. We connect the business community (companies, entrepreneurs and investors) to these UNM technologies for licensing opportunities and the creation of start-up companies. To learn more about us, visit our website at http://www.stc.unm.edu
Show less